SENHWA BIOSCIENCES, INC.
Update：2023/06/12
Industries
Main Industry
Biotechnology
Main Product/Service
1. G-quadruplex (stabilizer)
2. Casein Kinase 2 (inhibitor)
2. Casein Kinase 2 (inhibitor)
Founded Year
2012
Unified Business No.
54021973
Status
Active
Number of Employees
0
Total Paid-in
Capital
897,036,200 (NT$)
Location of Company
Taiwan
, New Taipei City
Exit Status
OTC listing(2017)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Senhwa Biosciences Inc. was established in 2012 and listed on the Taipei Exchange (TPEx) on April 24, 2017. The company aims to transform the model for new drug development by focusing on human efficacy. Senhwa believes that its dedication to science and rigorous processes will enable Senhwa to achieve remarkable milestones.
